This includes signaling through toll-like receptors (TLRs), among which activation of TLR4 expressed in innate immune cells plays a key role in HFD-induced hypothalamic inflammation and metabolic disease [[34], [35], [36]]. This evidence concerns the gene TLR4 and metabolic disease.